Related Experiment Video
Updated: Sep 1, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Learning size-adaptive molecular substructures for explainable drug-drug interaction prediction by substructure-aware
Ziduo Yang1, Weihe Zhong1, Qiujie Lv1
1Artificial Intelligence Medical Center, School of Intelligent Systems Engineering, Sun Yat-sen University Shenzhen 510275 China chenyuchian@mail.sysu.edu.cn +86 02039332153.
This study introduces a novel substructure-aware graph neural network (SA-DDI) for predicting drug-drug interactions (DDIs). The SA-DDI model effectively identifies key molecular substructures, improving prediction accuracy and interpretability.
Area of Science:
- Computational chemistry
- Pharmacology
- Machine learning
Background:
- Drug-drug interactions (DDIs) can lead to unpredictable pharmacological outcomes.
- Understanding the mechanisms behind DDIs is crucial but challenging.
- Current graph neural networks (GNNs) struggle to pinpoint critical substructures for DDI prediction.
Purpose of the Study:
- To develop an advanced GNN model for accurate DDI prediction.
- To enhance the interpretability of DDI prediction by identifying key contributing substructures.
- To address the limitations of existing GNNs in capturing substructure importance.
Main Methods:
- Introduced a substructure-aware graph neural network (SA-DDI).
- Incorporated a novel substructure attention mechanism to capture size- and shape-adaptive substructures.
- Utilized a substructure-substructure interaction module (SSIM) to model interactions between chemical substructures.
Main Results:
- The SA-DDI model outperformed state-of-the-art methods on two real-world DDI datasets.
- Visual interpretation demonstrated the model's sensitivity to drug structural information.
- The model successfully identified key substructures responsible for DDIs.
Conclusions:
- The SA-DDI model significantly improves the generalization and interpretation capabilities of DDI prediction.
- This approach offers a more transparent understanding of the molecular basis of drug-drug interactions.
- SA-DDI represents a significant advancement in computational pharmacology for drug safety assessment.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug-Receptor Bonds
In...
Protein-protein Interfaces
Quantitative Aspects of Drug-Receptor Interaction
Drug Discovery: Overview
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....